Einstein in the Media | U.S./Global

Nature highlights research by John Condeelis, Ph.D., that uses intravital imaging to reveal how breast cancer cells spread from the primary tumor.  Dr. Condeelis’s lab found that three types of cells – a macrophage (an immune cell), a tumor cell (primed for invasion) and an epithelial cell (which form the outer skin of blood vessles) form a type of “pump” to push tumor cells into the bloodstream. From there, they can travel to distant sites in the body. Dr. Condeelis is professor and co-chair of anatomy and structural biology and co-director of the Gruss Lipper Biophotonics Center, and the Judith and Burton P. Resnick Chair in Translational Research at Einstein. (Thursday, May 08, 2014)

More coverage on Dr. Condeelis | Dr. Condeelis' Profile

 
 

AAMC Reporter interviews John-Paul Sánchez, M.D., regarding changes in the Affordable Care Act that could help reduce health disparities for LGBT patients. Dr. Sánchez notes that additional training among physicians on providing care to the LGBT community is necessary. He also points out that many doctors may not realize that LGBT individuals who are minorities may face increased discrimination that in turn compromises their health. Dr. Sánchez is assistant professor of emergency medicine at Albert Einstein College of Medicine. (Friday, May 02, 2014)

Dr. Sanchez's Profile

 
 

The Washington Post interviews Brian Currie, M.D., M.P.H., about a new medical research data-sharing network to house the records of nearly 30 million Americans. The Patient-Centered Outcomes Research Institute’s network will make it easier to identify patients who could be invited to join clinical trials and conduct comparative effectiveness and clinical outcomes research. Dr. Currie is professor of clinical medicine and of clinical epidemiology & population health at Einstein and assistant dean for clinical research at Montefiore Medical Center. (Friday, April 18, 2014)

More coverage on Dr. Currie | Dr. Currie's Profile

 
 

CBSNews.com interviews Joel Zonszein, M.D., about a new report that found diabetes-related health complications have declined, including stroke. Dr. Zonszein notes that new medications and increasing educational programs that tackle smoking cessation and nutrition help prevent some diabetes-related complications. Dr. Zonszein is professor of clinical medicine at Albert Einstein College of Medicine and director of the Clinical Diabetes Center at Montefiore Medical Center. (Friday, April 18, 2014)

More coverage on Dr. Zonszein | Dr. Zonszein's Profile

 
 

New York Times interviews Geoffrey Kabat, Ph.D., about the usefulness of Body Mass Index (BMI) for measuring weight and obesity. Dr. Kabat notes that BMI actually misses more than half of people with excess body fat. Dr. Kabat is a senior epidemiologist at Einstein. (Monday, April 14, 2014)

 
 

How much dietary salt is necessary? NBC’s “The Today Show” features research by Michael Alderman, M.D., that found current salt guidelines may be too low for most Americans. The collaborative study by Dr. Alderman and researchers at the Copenhagen University Hospital found that the average daily sodium intake of most Americans (between around 2,600 milligrams to 5,000 milligrams daily) is actually associated with better health outcomes than many current recommended guidelines (below 2,300 mg/day). Dr. Alderman is distinguished university professor emeritus of epidemiology & population health and of medicine, and holds the Atran Foundation Chair in Social Medicine. (Wednesday, April 02, 2014)

More coverage on Dr. Alderman | Dr. Alderman's Profile

 
 

In a Nautilus profile, Dr. William Jacobs, Jr., discusses the key breakthroughs in his tuberculosis research and how losing his vision impacted his career path. The feature also includes an audio interview and animation of Dr. Jacobs talking about his shift from mathematics to bacterial genetics, his desire to help the underprivileged, and his goal to see the eradication of TB in his lifetime. Dr. Jacobs is professor of microbiology & immunology and of genetics at Einstein and a Howard Hughes Medical Institute investigator. (Monday, March 31, 2014)

More coverage on Dr. Jacobs, Jr. | Dr. Jacobs' Profile

 
 

NBCNews.com interviews Lisa Shulman, M.D., about new CDC estimates that 1 in 68 children have autism, a 30 percent jump from the 2008 estimate. Dr. Shulman noted that clinicians are seeing and diagnosing more children who previously had more limited access to evaluation, such as Hispanics, African-Americans and children who do well in school. Dr. Shulman is associate professor of clinical pediatrics and director of infant and toddler services at Einstein’s Children’s Evaluation and Rehabilitation Center and an attending physician at The Children’s Hospital at Montefiore. (Thursday, March 27, 2014)

More coverage on this story | More coverage on Dr. Shulman | Dr. Shulman's Profile

 
 

Wall Street Journal features new research by Nir Barzilai, M.D. that found lower levels of growth hormone are associated with extended lifespan in centenarians. Concerns about the dangers of using human growth hormone (HGH) as an anti-aging agent—a growing $4 billion industry—are increasing. Dr. Barzilai notes hormones that might have some beneficial effect for children with stunted growth may have a negative effect on aging adults. Dr. Barzilai is the Ingeborg and Ira Leon Rennert Chair of Aging Research and director of Einstein's Institute for Aging Research. (Tuesday, March 25, 2014)

More coverage on Dr. Barzilai | Dr. Barzilai's Profile

 
 

The New York Times reports on research by David Stein, M.D., and a team of scientists that successfully used “gene editing” technology to alter people’s cells to resist HIV. The New England Journal of Medicine study suggests that by homing in on and disabling a specific gene, it may eventually be possible to treat HIV without the use of antiretroviral drugs. The research team was led by the University of Pennsylvania and included Sangamo BioSciences.  Dr. Stein is associate professor of clinical medicine at Einstein and director of Adult HIV Research at Jacobi Medical Center. (Thursday, March 06, 2014)

More coverage on this story | Dr. Stein's Profile

 
 

The BBC Radio 4 program More or Less, interviews Paul Marantz, M.D., M.P.H., about a widely reported study in the British Medical Journal that found “an apple a day” was as effective as statins in preventing death. Dr. Marantz asserts that the journal’s publicity for the paper, published as part of the BMJ’s traditionally lighthearted Christmas issue, oversimplifies the issue and misleadingly compares the results of rigorous clinical trials for statins with much weaker observational data about food intake. Dr. Marantz came to the attention of the BBC as a result of a post he authored for Einstein’s blog, The Doctor’s Tablet. Dr. Marantz is associate dean for clinical research education and professor of clinical epidemiology & population health and of clinical medicine. (Segment begins at 21:00 of “Obesity Crisis?” episode, January 17, 2014) (Tuesday, January 21, 2014)

More coverage on Dr. Marantz | Dr. Marantz's Profile

 
 

WNYC Radio interviews Edward Burns, M.D., about the planned budget deal could restore some funding to the National Institutes of Health. Dr. Burns notes that the sequester – which cut budgets between five to ten percent – was deadly for research and might even stop young scientists from pursuing a research career. Dr. Burns is executive dean and professor of pathology and of medicine. (Audio begins at 1:32) (Thursday, December 19, 2013)

More coverage on Dr. Burns | Dr. Burns' Profile

 
 

NBC News features Ekaterina Dadachova, Ph.D., and her focus on radioimmunotherapy. Preclinical research shows it has the potential to eradicate HIV. The research, which uses radioactive isotopes to target cells, tested radioimmunotherapy on human blood samples and a laboratory model of the blood-brain barrier constructed of human cells. Dr. Dadachova is professor of radiology and of microbiology & immunology and the Sylvia and Robert S. Olnick Faculty Scholar in Cancer Research. (Friday, December 06, 2013)

More coverage on this story | Dr. Dadachova's Profile

 
 

The Wall Street Journal highlights groundbreaking research by Steven Walkley, D.V.M., Ph.D., that has led to treatment options for the rare condition Niemann-Pick Type C. In a lengthy cover story covering at least six years of reporting, journalist Amy Marcus details the passion that drove Walkley to continue his research on the drug cyclodextrin – and explores how parents and scientists have joined forces to find more effective treatments. (Thursday, November 14, 2013)

See Multimedia Version of this Feature | More coverage on Dr. Walkley | Dr. Walkley's Profile

 
 

The Scientist profiles Ana Maria Cuervo, M.D., Ph.D., detailing her career path and research in autophagy. The career retrospective follows Dr. Cuervo’s career from her first medical student project in Spain to her arrival at Einstein. Dr. Cuervo is professor of developmental and molecular biology, of anatomy and structural biology, and of medicine and holds the Robert and Renée Belfer Chair for the Study of Neurodegenerative Diseases at Einstein. (Friday, November 01, 2013)

More coverage on Dr. Cuervo | Dr. Cuervo's Profile

 
 
First Page | Previous Page | Page of 13 | Next Page | Last Page